PI
Pacegenix, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$22.5Msold at filing
Total offering$22.5M
Investors in the raise15count reported to the SEC
FiledMar 26, 2026first sale Mar 11, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jay Glenn WohlgemuthExecutive Officer, Director
Fredric Neville EshelmanDirector
Raymond Glenn TabibiazarDirector
Frank Neville Grazzini, IIExecutive Officer
Executive officers, directors and promoters as listed on the Form D.